Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2018 02:00 ET | Source: Nuvaira

Nuvaira kündigt Vortrag zur Bedeutung der zielgerichteten Lungendenervierung bei der Behandlung von COPD auf dem Internationalen Kongress der ERS an

PARIS, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Nuvaira, ein Unternehmen, das medizinische Geräte zur Behandlung von obstruktiven Lungenkrankheiten entwickelt, hat heute die Annahme eines klinischen...
September 18, 2018 02:00 ET | Source: Nuvaira

Nuvaira annonce un exposé oral lors du congrès international de l’ERS pour discuter de l’importance de la dénervation ciblée du poumon afin de traiter la BPCO

PARIS, 18 sept. 2018 (GLOBE NEWSWIRE) -- Nuvaira, un développeur de dispositifs médicaux pour traiter les maladies pulmonaires obstructives, a annoncé aujourd’hui l’acceptation par la European...
September 18, 2018 02:00 ET | Source: Nuvaira, Inc.

Nuvaira Announces Oral Presentation at ERS International Congress Discussing Significance of Targeted Lung Denervation to Treat COPD

PARIS, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, announced the acceptance of a clinical abstract by the European Respiratory...
March 27, 2018 08:00 ET | Source: Nuvaira, Inc.

Nuvaira Announces 1st Patient Treated in RELIEF-1 Study Evaluating New Approach for Asthma Treatment

MINNEAPOLIS, March 27, 2018 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced treatment of the first patient in the RELIEF-1 Clinical...
September 07, 2017 08:00 ET | Source: Nuvaira, Inc.

Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress

MILAN, Italy, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced that four scientific abstracts featuring the Nuvaira™...
June 27, 2017 09:00 ET | Source: Nuvaira, Inc.

Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD

MINNEAPOLIS, June 27, 2017 (GLOBE NEWSWIRE) -- Nuvaira (formerly known as Holaira), a developer of medical devices to treat obstructive lung diseases, today announced completion of patient...
June 20, 2017 09:00 ET | Source: Nuvaira, Inc.

Holaira Announces Company Name Change to Nuvaira

MINNEAPOLIS, June 20, 2017 (GLOBE NEWSWIRE) -- Holaira, a developer of medical devices to treat obstructive lung diseases, today announced that it has changed its name to Nuvaira, effective...